Kelly Doran
Concepts (379)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Streptococcal Infections | 49 | 2025 | 144 | 17.610 |
Why?
| Streptococcus agalactiae | 61 | 2025 | 92 | 16.830 |
Why?
| Vagina | 21 | 2025 | 175 | 7.190 |
Why?
| Blood-Brain Barrier | 20 | 2023 | 129 | 4.700 |
Why?
| Meningitis, Bacterial | 17 | 2023 | 51 | 4.580 |
Why?
| Bacterial Proteins | 37 | 2025 | 826 | 4.520 |
Why?
| Virulence | 23 | 2025 | 254 | 3.730 |
Why?
| Type VII Secretion Systems | 5 | 2024 | 7 | 2.830 |
Why?
| Adhesins, Bacterial | 11 | 2022 | 40 | 2.450 |
Why?
| Bacterial Adhesion | 17 | 2020 | 91 | 2.440 |
Why?
| Brain | 20 | 2023 | 2618 | 2.210 |
Why?
| Premature Birth | 4 | 2022 | 311 | 1.850 |
Why?
| Host-Pathogen Interactions | 10 | 2024 | 348 | 1.630 |
Why?
| Mice | 56 | 2025 | 16579 | 1.570 |
Why?
| Vimentin | 3 | 2022 | 50 | 1.550 |
Why?
| Endothelium, Vascular | 9 | 2019 | 871 | 1.420 |
Why?
| Fimbriae, Bacterial | 6 | 2020 | 28 | 1.380 |
Why?
| Animals | 66 | 2025 | 34501 | 1.290 |
Why?
| Antigens, Bacterial | 3 | 2019 | 120 | 1.260 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 4 | 2025 | 212 | 1.200 |
Why?
| Disease Models, Animal | 21 | 2025 | 3943 | 1.190 |
Why?
| Neutrophils | 11 | 2024 | 1188 | 1.170 |
Why?
| Glycolipids | 3 | 2024 | 42 | 1.130 |
Why?
| Endothelial Cells | 11 | 2015 | 701 | 1.130 |
Why?
| Staphylococcus aureus | 4 | 2025 | 425 | 1.110 |
Why?
| Fimbriae Proteins | 4 | 2013 | 15 | 1.050 |
Why?
| Chemokines | 4 | 2022 | 221 | 1.050 |
Why?
| Streptococcus | 4 | 2022 | 25 | 1.050 |
Why?
| Bacterial Toxins | 5 | 2024 | 106 | 1.000 |
Why?
| Skin | 2 | 2025 | 717 | 0.980 |
Why?
| Malassezia | 1 | 2025 | 3 | 0.980 |
Why?
| Mycobiome | 1 | 2025 | 10 | 0.970 |
Why?
| Gene Expression Regulation, Bacterial | 13 | 2025 | 322 | 0.960 |
Why?
| Lactoylglutathione Lyase | 1 | 2025 | 17 | 0.960 |
Why?
| Microbial Interactions | 2 | 2024 | 17 | 0.950 |
Why?
| Pyruvaldehyde | 1 | 2025 | 43 | 0.930 |
Why?
| Cell Line | 19 | 2020 | 2731 | 0.910 |
Why?
| Leukocyte L1 Antigen Complex | 2 | 2022 | 29 | 0.910 |
Why?
| Wound Infection | 1 | 2023 | 32 | 0.830 |
Why?
| Virulence Factors | 9 | 2025 | 153 | 0.820 |
Why?
| Endothelium | 2 | 2021 | 106 | 0.820 |
Why?
| Meningitis, Pneumococcal | 2 | 2014 | 7 | 0.820 |
Why?
| Gene Expression Regulation | 6 | 2021 | 2506 | 0.810 |
Why?
| Protein Kinases | 3 | 2016 | 309 | 0.810 |
Why?
| Milk, Human | 2 | 2022 | 147 | 0.810 |
Why?
| Bacterial Outer Membrane Proteins | 1 | 2023 | 58 | 0.790 |
Why?
| Chorioamnionitis | 1 | 2022 | 39 | 0.780 |
Why?
| Membrane Lipids | 1 | 2023 | 91 | 0.780 |
Why?
| Bacillus anthracis | 3 | 2011 | 12 | 0.780 |
Why?
| Manganese | 1 | 2022 | 60 | 0.780 |
Why?
| Fibrinogen | 4 | 2019 | 158 | 0.770 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2023 | 174 | 0.760 |
Why?
| Humans | 75 | 2025 | 128524 | 0.750 |
Why?
| Enterococcus faecalis | 2 | 2024 | 27 | 0.750 |
Why?
| Nod2 Signaling Adaptor Protein | 1 | 2021 | 33 | 0.740 |
Why?
| Zinc | 2 | 2022 | 292 | 0.720 |
Why?
| Anthrax | 2 | 2011 | 9 | 0.700 |
Why?
| Mutation | 17 | 2025 | 3692 | 0.700 |
Why?
| Hemolysin Proteins | 7 | 2012 | 34 | 0.670 |
Why?
| Gram-Positive Bacterial Infections | 1 | 2020 | 63 | 0.670 |
Why?
| Female | 35 | 2025 | 68127 | 0.610 |
Why?
| Biological Products | 1 | 2022 | 200 | 0.610 |
Why?
| Tight Junctions | 3 | 2023 | 75 | 0.600 |
Why?
| Microbiota | 2 | 2025 | 720 | 0.600 |
Why?
| Teichoic Acids | 2 | 2010 | 13 | 0.600 |
Why?
| Genome, Bacterial | 4 | 2025 | 134 | 0.580 |
Why?
| Pregnancy Complications, Infectious | 3 | 2019 | 335 | 0.570 |
Why?
| Autophagy | 3 | 2016 | 266 | 0.570 |
Why?
| Pregnancy | 9 | 2023 | 6297 | 0.570 |
Why?
| Sepsis | 4 | 2022 | 556 | 0.560 |
Why?
| Peptides | 2 | 2013 | 909 | 0.550 |
Why?
| Oxidoreductases | 2 | 2008 | 90 | 0.540 |
Why?
| Infant, Newborn | 8 | 2023 | 5687 | 0.540 |
Why?
| Plasmids | 6 | 2009 | 357 | 0.540 |
Why?
| Complement C5a | 2 | 2013 | 67 | 0.520 |
Why?
| Transcriptional Activation | 1 | 2018 | 355 | 0.520 |
Why?
| Astrocytes | 2 | 2015 | 189 | 0.510 |
Why?
| Interleukin-8 | 5 | 2015 | 258 | 0.500 |
Why?
| Meninges | 3 | 2023 | 40 | 0.500 |
Why?
| Mutagenesis | 4 | 2025 | 181 | 0.490 |
Why?
| Staphylococcal Infections | 4 | 2025 | 380 | 0.470 |
Why?
| Cells, Cultured | 9 | 2021 | 4008 | 0.470 |
Why?
| Lipopolysaccharides | 2 | 2010 | 856 | 0.460 |
Why?
| Diabetes Mellitus | 1 | 2023 | 1001 | 0.450 |
Why?
| Cell Membrane | 2 | 2010 | 722 | 0.450 |
Why?
| Larva | 1 | 2015 | 210 | 0.440 |
Why?
| Genitalia, Female | 3 | 2024 | 38 | 0.440 |
Why?
| Reproductive Tract Infections | 1 | 2013 | 1 | 0.440 |
Why?
| Zebrafish | 2 | 2015 | 464 | 0.430 |
Why?
| Neuraminidase | 2 | 2010 | 24 | 0.430 |
Why?
| Streptococcus pneumoniae | 3 | 2023 | 159 | 0.420 |
Why?
| MAP Kinase Signaling System | 1 | 2015 | 302 | 0.420 |
Why?
| Parasites | 1 | 2013 | 39 | 0.410 |
Why?
| Signal Transduction | 7 | 2015 | 4829 | 0.400 |
Why?
| Gram-Positive Bacteria | 2 | 2023 | 45 | 0.400 |
Why?
| Gene Expression Profiling | 8 | 2021 | 1687 | 0.400 |
Why?
| Repressor Proteins | 2 | 2013 | 400 | 0.390 |
Why?
| Viruses | 1 | 2013 | 99 | 0.390 |
Why?
| Integrin alpha2beta1 | 1 | 2011 | 3 | 0.380 |
Why?
| Staphylococcal Skin Infections | 1 | 2011 | 33 | 0.370 |
Why?
| Membrane Glycoproteins | 1 | 2014 | 466 | 0.370 |
Why?
| Anti-Bacterial Agents | 4 | 2021 | 1667 | 0.370 |
Why?
| DNA Replication | 4 | 1999 | 224 | 0.350 |
Why?
| Phagocytes | 2 | 2008 | 96 | 0.330 |
Why?
| Bacteria | 2 | 2013 | 811 | 0.330 |
Why?
| Oligosaccharides | 2 | 2022 | 57 | 0.330 |
Why?
| Immunologic Factors | 1 | 2011 | 229 | 0.320 |
Why?
| Microcirculation | 2 | 2011 | 137 | 0.320 |
Why?
| Immunity, Innate | 3 | 2016 | 803 | 0.300 |
Why?
| Intestinal Mucosa | 1 | 2013 | 575 | 0.300 |
Why?
| Escherichia coli | 5 | 2013 | 770 | 0.300 |
Why?
| Operon | 2 | 2023 | 63 | 0.280 |
Why?
| Transcription Factors | 2 | 2015 | 1631 | 0.280 |
Why?
| Genomics | 3 | 2022 | 716 | 0.270 |
Why?
| Cerebrovascular Circulation | 1 | 2008 | 221 | 0.260 |
Why?
| Mice, Inbred C57BL | 7 | 2020 | 5257 | 0.250 |
Why?
| Serotyping | 2 | 2019 | 28 | 0.250 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 814 | 0.250 |
Why?
| Helicobacter Infections | 2 | 2017 | 28 | 0.250 |
Why?
| Epithelial Cells | 6 | 2018 | 1036 | 0.240 |
Why?
| Mice, Knockout | 5 | 2020 | 2752 | 0.240 |
Why?
| Mice, Inbred BALB C | 3 | 2019 | 1229 | 0.240 |
Why?
| Myeloid Differentiation Factor 88 | 2 | 2017 | 95 | 0.230 |
Why?
| Replication Origin | 3 | 1999 | 17 | 0.230 |
Why?
| DNA-Binding Proteins | 4 | 1999 | 1415 | 0.230 |
Why?
| Stomach Neoplasms | 2 | 2017 | 98 | 0.230 |
Why?
| DNA, Bacterial | 5 | 2004 | 324 | 0.230 |
Why?
| DNA Transposable Elements | 1 | 2025 | 119 | 0.220 |
Why?
| DNA-Cytosine Methylases | 1 | 2023 | 4 | 0.220 |
Why?
| Biological Transport | 3 | 2022 | 394 | 0.220 |
Why?
| Colony Count, Microbial | 2 | 2014 | 116 | 0.220 |
Why?
| Zonula Occludens-1 Protein | 2 | 2015 | 15 | 0.220 |
Why?
| Receptors, Interleukin-8B | 2 | 2013 | 24 | 0.210 |
Why?
| HeLa Cells | 3 | 2021 | 603 | 0.210 |
Why?
| Neuroimmunomodulation | 1 | 2023 | 66 | 0.210 |
Why?
| Keratin-19 | 1 | 2022 | 3 | 0.210 |
Why?
| Bacteremia | 1 | 2025 | 188 | 0.200 |
Why?
| Coxsackievirus Infections | 2 | 2013 | 13 | 0.200 |
Why?
| Paraquat | 1 | 2022 | 15 | 0.200 |
Why?
| RNA, Bacterial | 2 | 2021 | 182 | 0.190 |
Why?
| Meningitis | 2 | 2022 | 80 | 0.190 |
Why?
| RNA, Small Untranslated | 1 | 2021 | 15 | 0.190 |
Why?
| Mucins | 1 | 2022 | 69 | 0.190 |
Why?
| beta Catenin | 1 | 2023 | 219 | 0.180 |
Why?
| Amino Acid Sequence | 4 | 2015 | 2041 | 0.180 |
Why?
| Carcinoembryonic Antigen | 1 | 2021 | 41 | 0.180 |
Why?
| Diseases in Twins | 1 | 2002 | 176 | 0.180 |
Why?
| Glycoproteins | 2 | 2013 | 337 | 0.180 |
Why?
| Ethanolamine | 1 | 2020 | 5 | 0.180 |
Why?
| Chemotaxis, Leukocyte | 2 | 2011 | 136 | 0.180 |
Why?
| Hydrogen Peroxide | 1 | 2022 | 308 | 0.180 |
Why?
| Escherichia coli Proteins | 2 | 1999 | 177 | 0.180 |
Why?
| Transcription, Genetic | 3 | 2023 | 1398 | 0.170 |
Why?
| Fluorescent Antibody Technique | 3 | 2016 | 374 | 0.170 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 937 | 0.170 |
Why?
| Cell Adhesion Molecules | 1 | 2021 | 172 | 0.170 |
Why?
| Drug Resistance, Microbial | 1 | 2019 | 63 | 0.170 |
Why?
| Michigan | 1 | 2019 | 103 | 0.170 |
Why?
| Mucin-5B | 1 | 2022 | 218 | 0.160 |
Why?
| Disease Susceptibility | 1 | 2021 | 334 | 0.160 |
Why?
| Molecular Sequence Data | 4 | 2015 | 2818 | 0.160 |
Why?
| Mice, Mutant Strains | 1 | 2019 | 292 | 0.150 |
Why?
| Homeostasis | 1 | 2022 | 605 | 0.150 |
Why?
| Vaginosis, Bacterial | 1 | 2018 | 12 | 0.150 |
Why?
| Antigens, CD | 1 | 2021 | 479 | 0.150 |
Why?
| Iron | 1 | 2019 | 281 | 0.140 |
Why?
| Helicobacter pylori | 2 | 2017 | 37 | 0.140 |
Why?
| Sequence Analysis, RNA | 1 | 2019 | 428 | 0.140 |
Why?
| Central Nervous System | 2 | 2023 | 255 | 0.140 |
Why?
| Serine Endopeptidases | 1 | 2017 | 117 | 0.140 |
Why?
| Choroid Plexus | 2 | 2013 | 4 | 0.130 |
Why?
| Polymerase Chain Reaction | 2 | 2010 | 1019 | 0.130 |
Why?
| Induced Pluripotent Stem Cells | 1 | 2019 | 223 | 0.130 |
Why?
| Sheep | 1 | 2019 | 827 | 0.130 |
Why?
| Cell Movement | 2 | 2016 | 937 | 0.130 |
Why?
| N-Acetylmuramoyl-L-alanine Amidase | 1 | 2016 | 7 | 0.130 |
Why?
| Microtubule-Associated Proteins | 2 | 2014 | 189 | 0.130 |
Why?
| Genes, Regulator | 1 | 2016 | 33 | 0.130 |
Why?
| Mast Cells | 1 | 2017 | 142 | 0.130 |
Why?
| Organelle Biogenesis | 1 | 2016 | 14 | 0.130 |
Why?
| Claudin-5 | 1 | 2015 | 2 | 0.120 |
Why?
| Snail Family Transcription Factors | 1 | 2015 | 16 | 0.120 |
Why?
| Biological Assay | 1 | 2016 | 118 | 0.120 |
Why?
| Myoblasts | 1 | 2016 | 80 | 0.120 |
Why?
| Muscle Development | 1 | 2016 | 103 | 0.120 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2015 | 148 | 0.120 |
Why?
| Coculture Techniques | 1 | 2015 | 225 | 0.120 |
Why?
| Gene Regulatory Networks | 1 | 2017 | 281 | 0.120 |
Why?
| Enterovirus B, Human | 1 | 2014 | 25 | 0.110 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2015 | 179 | 0.110 |
Why?
| Male | 10 | 2022 | 62883 | 0.110 |
Why?
| Phagosomes | 1 | 2014 | 42 | 0.110 |
Why?
| Virus Shedding | 1 | 2014 | 41 | 0.110 |
Why?
| Lymphocytic Choriomeningitis | 1 | 2013 | 13 | 0.110 |
Why?
| Vaginal Diseases | 1 | 2014 | 22 | 0.110 |
Why?
| Genetic Fitness | 1 | 2014 | 54 | 0.110 |
Why?
| Survival Analysis | 2 | 2015 | 1265 | 0.110 |
Why?
| Integrins | 1 | 2014 | 92 | 0.110 |
Why?
| Serine | 1 | 2014 | 136 | 0.110 |
Why?
| Macrophages | 4 | 2023 | 1463 | 0.110 |
Why?
| Receptor, Anaphylatoxin C5a | 1 | 2013 | 30 | 0.110 |
Why?
| Recombinant Fusion Proteins | 1 | 2016 | 632 | 0.110 |
Why?
| Immunologic Deficiency Syndromes | 1 | 2013 | 62 | 0.110 |
Why?
| Cell-Derived Microparticles | 1 | 2014 | 61 | 0.100 |
Why?
| Bacterial Translocation | 1 | 2013 | 39 | 0.100 |
Why?
| Protein Transport | 1 | 2014 | 422 | 0.100 |
Why?
| Epithelium | 1 | 2014 | 306 | 0.100 |
Why?
| Sequence Alignment | 2 | 2015 | 330 | 0.100 |
Why?
| Interleukin-1beta | 1 | 2015 | 374 | 0.100 |
Why?
| Mucus | 1 | 2013 | 74 | 0.100 |
Why?
| Blotting, Western | 1 | 2015 | 1168 | 0.100 |
Why?
| Zebrafish Proteins | 1 | 2015 | 269 | 0.100 |
Why?
| Species Specificity | 1 | 2013 | 567 | 0.100 |
Why?
| Neural Stem Cells | 1 | 2013 | 137 | 0.100 |
Why?
| Arylsulfotransferase | 1 | 2011 | 3 | 0.100 |
Why?
| Bacteriophages | 1 | 2013 | 92 | 0.090 |
Why?
| Phosphoprotein Phosphatases | 1 | 2011 | 67 | 0.090 |
Why?
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2011 | 34 | 0.090 |
Why?
| Phagocytosis | 1 | 2013 | 364 | 0.090 |
Why?
| Bacterial Physiological Phenomena | 1 | 2012 | 58 | 0.090 |
Why?
| Lung | 2 | 2017 | 3741 | 0.090 |
Why?
| DNA Primers | 2 | 2009 | 510 | 0.090 |
Why?
| Medicaid | 1 | 2015 | 437 | 0.090 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 756 | 0.090 |
Why?
| Enterovirus Infections | 1 | 2014 | 171 | 0.090 |
Why?
| Cathelicidins | 2 | 2008 | 40 | 0.090 |
Why?
| Flow Cytometry | 1 | 2015 | 1141 | 0.090 |
Why?
| Immunohistochemistry | 1 | 2015 | 1669 | 0.090 |
Why?
| Chemokine CCL20 | 1 | 2010 | 5 | 0.090 |
Why?
| Chemokine CXCL2 | 1 | 2010 | 43 | 0.090 |
Why?
| Antimicrobial Cationic Peptides | 2 | 2008 | 79 | 0.090 |
Why?
| Microvessels | 1 | 2011 | 79 | 0.090 |
Why?
| Chemokine CXCL1 | 1 | 2010 | 73 | 0.090 |
Why?
| Brazil | 2 | 2021 | 104 | 0.090 |
Why?
| Lectins | 1 | 2010 | 46 | 0.090 |
Why?
| Biomarkers | 1 | 2021 | 3881 | 0.090 |
Why?
| Biomarkers, Tumor | 1 | 2017 | 1182 | 0.080 |
Why?
| Neutrophil Infiltration | 1 | 2010 | 97 | 0.080 |
Why?
| Cell Wall | 1 | 2010 | 53 | 0.080 |
Why?
| Binding Sites | 4 | 2021 | 1239 | 0.080 |
Why?
| Mice, Transgenic | 1 | 2014 | 2069 | 0.080 |
Why?
| Protein Binding | 4 | 2021 | 2097 | 0.080 |
Why?
| Salmonella typhimurium | 1 | 2010 | 176 | 0.080 |
Why?
| Placenta | 2 | 2013 | 714 | 0.080 |
Why?
| Myeloid Cells | 1 | 2010 | 142 | 0.080 |
Why?
| Blindness | 1 | 2009 | 37 | 0.080 |
Why?
| Phosphoproteins | 1 | 2011 | 330 | 0.080 |
Why?
| Lactococcus lactis | 1 | 2008 | 2 | 0.070 |
Why?
| Gene Expression | 1 | 2013 | 1462 | 0.070 |
Why?
| Microscopy | 1 | 2009 | 140 | 0.070 |
Why?
| Cell Differentiation | 1 | 2016 | 1883 | 0.070 |
Why?
| Deafness | 1 | 2009 | 80 | 0.070 |
Why?
| Macrophages, Peritoneal | 1 | 2008 | 90 | 0.070 |
Why?
| Cerebral Palsy | 1 | 2009 | 92 | 0.070 |
Why?
| Streptolysins | 1 | 2006 | 8 | 0.070 |
Why?
| Adult | 4 | 2022 | 35315 | 0.070 |
Why?
| Drug Resistance, Bacterial | 1 | 2008 | 173 | 0.070 |
Why?
| Streptococcus pyogenes | 1 | 2006 | 33 | 0.070 |
Why?
| Models, Neurological | 1 | 2008 | 235 | 0.070 |
Why?
| Trophoblasts | 1 | 2008 | 189 | 0.060 |
Why?
| Neoplasms | 1 | 2021 | 2465 | 0.060 |
Why?
| Seizures | 1 | 2009 | 395 | 0.060 |
Why?
| Cognition Disorders | 1 | 2009 | 496 | 0.060 |
Why?
| Cytotoxins | 1 | 2004 | 16 | 0.060 |
Why?
| Inflammation | 2 | 2013 | 2664 | 0.060 |
Why?
| Membrane Proteins | 1 | 2011 | 1108 | 0.060 |
Why?
| Carotenoids | 1 | 2004 | 38 | 0.060 |
Why?
| Emergency Service, Hospital | 1 | 2015 | 1968 | 0.060 |
Why?
| Receptor Activity-Modifying Protein 1 | 1 | 2023 | 2 | 0.050 |
Why?
| Arachnoid | 1 | 2023 | 12 | 0.050 |
Why?
| NAV1.8 Voltage-Gated Sodium Channel | 1 | 2023 | 3 | 0.050 |
Why?
| Nociceptors | 1 | 2023 | 20 | 0.050 |
Why?
| Calcitonin Gene-Related Peptide | 1 | 2023 | 39 | 0.050 |
Why?
| DNA Footprinting | 2 | 1999 | 33 | 0.050 |
Why?
| Aminoacyltransferases | 1 | 2022 | 3 | 0.050 |
Why?
| Fibronectins | 1 | 2022 | 119 | 0.050 |
Why?
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 2002 | 10 | 0.050 |
Why?
| Cations | 1 | 2022 | 79 | 0.050 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 1 | 2022 | 167 | 0.050 |
Why?
| Fatal Outcome | 1 | 2002 | 301 | 0.050 |
Why?
| Treatment Outcome | 2 | 2016 | 10163 | 0.050 |
Why?
| Twins, Monozygotic | 1 | 2002 | 209 | 0.050 |
Why?
| Cricetulus | 1 | 2021 | 104 | 0.040 |
Why?
| CHO Cells | 1 | 2021 | 150 | 0.040 |
Why?
| RNA Stability | 1 | 2021 | 100 | 0.040 |
Why?
| GPI-Linked Proteins | 1 | 2021 | 67 | 0.040 |
Why?
| Cricetinae | 1 | 2021 | 275 | 0.040 |
Why?
| Drug Resistance, Multiple, Bacterial | 1 | 2021 | 66 | 0.040 |
Why?
| Age of Onset | 1 | 2002 | 493 | 0.040 |
Why?
| Chromatography, Liquid | 1 | 2022 | 374 | 0.040 |
Why?
| Protein Conformation | 2 | 2013 | 853 | 0.040 |
Why?
| Molecular Sequence Annotation | 1 | 2020 | 88 | 0.040 |
Why?
| Mutagenesis, Site-Directed | 2 | 2013 | 358 | 0.040 |
Why?
| Public Health Surveillance | 1 | 2020 | 67 | 0.040 |
Why?
| Transformation, Genetic | 1 | 1999 | 15 | 0.040 |
Why?
| Microbial Sensitivity Tests | 1 | 2021 | 335 | 0.040 |
Why?
| Tandem Mass Spectrometry | 1 | 2022 | 450 | 0.040 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1999 | 87 | 0.040 |
Why?
| Phosphorylation | 2 | 2015 | 1681 | 0.040 |
Why?
| Carrier Proteins | 1 | 2022 | 731 | 0.040 |
Why?
| Animals, Newborn | 2 | 2011 | 805 | 0.040 |
Why?
| Sequence Analysis | 1 | 1998 | 38 | 0.040 |
Why?
| Models, Molecular | 2 | 2013 | 1481 | 0.040 |
Why?
| Chymases | 1 | 2017 | 4 | 0.040 |
Why?
| DNA Helicases | 1 | 1999 | 149 | 0.040 |
Why?
| Disease Progression | 2 | 2017 | 2603 | 0.040 |
Why?
| Enzyme Activation | 1 | 1999 | 799 | 0.040 |
Why?
| Pain | 1 | 2023 | 756 | 0.030 |
Why?
| Mastitis | 1 | 2016 | 4 | 0.030 |
Why?
| Phylogeny | 1 | 2020 | 846 | 0.030 |
Why?
| Carrier State | 1 | 2016 | 60 | 0.030 |
Why?
| Genotype | 1 | 2021 | 1831 | 0.030 |
Why?
| Rats | 2 | 2016 | 5168 | 0.030 |
Why?
| Macrolides | 1 | 2016 | 62 | 0.030 |
Why?
| Computational Biology | 1 | 2020 | 597 | 0.030 |
Why?
| Histidine Kinase | 1 | 2015 | 33 | 0.030 |
Why?
| Oxidative Phosphorylation | 1 | 2016 | 184 | 0.030 |
Why?
| Muscle Fibers, Skeletal | 1 | 2016 | 190 | 0.030 |
Why?
| Mice, Inbred Strains | 1 | 2015 | 402 | 0.030 |
Why?
| Carbonic Anhydrase II | 1 | 2013 | 4 | 0.030 |
Why?
| Osteomyelitis | 1 | 2016 | 124 | 0.030 |
Why?
| Nestin | 1 | 2013 | 19 | 0.030 |
Why?
| Gastric Mucosa | 1 | 2013 | 50 | 0.030 |
Why?
| Microarray Analysis | 1 | 2013 | 121 | 0.030 |
Why?
| Health Care Surveys | 1 | 2015 | 557 | 0.030 |
Why?
| Adhesiveness | 1 | 2013 | 19 | 0.030 |
Why?
| Bacteriophage T4 | 1 | 2013 | 15 | 0.030 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2014 | 137 | 0.030 |
Why?
| X-Ray Diffraction | 1 | 2013 | 94 | 0.030 |
Why?
| Models, Immunological | 1 | 2013 | 94 | 0.030 |
Why?
| Substrate Specificity | 1 | 2013 | 367 | 0.030 |
Why?
| Sequence Analysis, Protein | 1 | 2012 | 28 | 0.030 |
Why?
| Carbon | 1 | 2014 | 207 | 0.030 |
Why?
| Cluster Analysis | 1 | 2014 | 478 | 0.030 |
Why?
| Phenotype | 2 | 2014 | 3050 | 0.030 |
Why?
| Symbiosis | 1 | 2013 | 70 | 0.030 |
Why?
| Precancerous Conditions | 1 | 2013 | 161 | 0.020 |
Why?
| Extracellular Matrix Proteins | 1 | 2013 | 141 | 0.020 |
Why?
| Viral Proteins | 1 | 2014 | 321 | 0.020 |
Why?
| Computer Simulation | 1 | 2016 | 939 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2013 | 836 | 0.020 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2011 | 87 | 0.020 |
Why?
| Apoptosis | 2 | 2013 | 2437 | 0.020 |
Why?
| Cell Death | 1 | 2012 | 348 | 0.020 |
Why?
| Tumor Cells, Cultured | 1 | 2012 | 927 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2015 | 1199 | 0.020 |
Why?
| In Situ Hybridization | 1 | 2010 | 292 | 0.020 |
Why?
| N-Acetylneuraminic Acid | 1 | 2009 | 10 | 0.020 |
Why?
| Mitochondria | 1 | 2016 | 844 | 0.020 |
Why?
| Adolescent | 2 | 2021 | 20213 | 0.020 |
Why?
| Microscopy, Confocal | 1 | 2010 | 308 | 0.020 |
Why?
| Streptococcal Vaccines | 1 | 2008 | 6 | 0.020 |
Why?
| Models, Biological | 1 | 2016 | 1693 | 0.020 |
Why?
| Infant | 1 | 2002 | 8913 | 0.020 |
Why?
| Risk Factors | 1 | 2002 | 9727 | 0.020 |
Why?
| Cell Adhesion | 1 | 2009 | 444 | 0.020 |
Why?
| Genetic Complementation Test | 1 | 2007 | 63 | 0.020 |
Why?
| Base Sequence | 2 | 2004 | 2134 | 0.020 |
Why?
| Protein Processing, Post-Translational | 1 | 2010 | 450 | 0.020 |
Why?
| Middle Aged | 2 | 2021 | 30893 | 0.020 |
Why?
| Bacterial Capsules | 1 | 2006 | 28 | 0.020 |
Why?
| Cysteine Endopeptidases | 1 | 2006 | 67 | 0.020 |
Why?
| Culture Media | 1 | 2006 | 167 | 0.020 |
Why?
| Cell Proliferation | 1 | 2013 | 2335 | 0.020 |
Why?
| Stem Cells | 1 | 2010 | 578 | 0.020 |
Why?
| Cytokines | 1 | 2013 | 1985 | 0.020 |
Why?
| Proteomics | 1 | 2011 | 1004 | 0.010 |
Why?
| Cell Line, Tumor | 1 | 2012 | 3160 | 0.010 |
Why?
| Hyaluronic Acid | 1 | 2006 | 212 | 0.010 |
Why?
| Young Adult | 1 | 2021 | 12320 | 0.010 |
Why?
| Genes, Bacterial | 1 | 2004 | 158 | 0.010 |
Why?
| Cell Survival | 1 | 2006 | 1077 | 0.010 |
Why?
| Biomedical Research | 1 | 2008 | 646 | 0.010 |
Why?
| Neurons | 1 | 2010 | 1448 | 0.010 |
Why?
| Reactive Oxygen Species | 1 | 2004 | 579 | 0.010 |
Why?
| United States | 1 | 2015 | 13876 | 0.010 |
Why?
| Time Factors | 1 | 2007 | 6503 | 0.010 |
Why?
| Chromosome Mapping | 1 | 1997 | 505 | 0.010 |
Why?
| Adenosine Triphosphate | 1 | 1997 | 470 | 0.010 |
Why?
|
|
Doran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|